Statistical Thinking for Non-Statisticians in Drug Regulation - Image 1

£60.99

Wiley-Blackwell Statistical Thinking for Non-Statisticians in Drug Regulation

Name: Statistical Thinking for Non-Statisticians in Drug Regulation
Brand: Wiley-Blackwell
Price: 60.99 GBP
Availability: InStock

9781119867388

Pharmacy - Dispensing

This is the usual price. Wait for it to drop, or tell us your number.

£61 today · usual range £0–£0 · best ever £50

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 239 days • 215 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 239 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £57-59 (69 days, 32.1%)

Price range: £50 - £61

Price levels: 5 price ranges over 215 days

Description

STATISTICAL THINKING FOR NON-STATISTICIANS IN DRUG REGULATION Statistical methods in the pharmaceutical industry are accepted as a key element in the design and analysis of clinical studies. Increasingly, the medical and scientific community are aligning with the regulatory authorities and recognizing that correct statistical methodology is essential as the basis for valid conclusions. In order for those correct and robust methods to be successfully employed there needs to be effective communication across disciplines at all stages of the planning, conducting, analyzing and reporting of clinical studies associated with the development and evaluation of new drugs and devices. Statistical Thinking for Non-Statisticians in Drug Regulation provides a comprehensive in-depth guide to statistical methodology for pharmaceutical industry professionals, including physicians, investigators, medical science liaisons, clinical research scientists, medical writers, regulatory personnel, statistical programmers, senior data managers and those working in pharmacovigilance. The author’s years of experience and up-to-date familiarity with pharmaceutical regulations and statistical practice within the wider clinical community make this an essential guide for the those working in and with the industry. The third edition of Statistical Thinking for Non-Statisticians in Drug Regulation includes: A detailed new chapter on Estimands in line with the 2019 Addendum to ICH E9 Major new sections on topics including Combining Hierarchical Testing and Alpha Adjustment, Biosimilars, Restricted Mean Survival Time, Composite Endpoints and Cumulative Incidence Functions, Adjusting for Cross-Over in Oncology, Inverse Propensity Score Weighting, and Network Meta-Analysis Updated coverage of many existing topics to reflect new and revised guidance from regulatory authorities and author experience Statistical Thinking for Non-Statisticians in Drug Regulation is a valuable guide for pharmaceutical and medical device industry professionals, as well as statisticians joining the pharmaceutical industry and students and teachers of drug development.

Key Features

New Store Stock

Product Specifications

Brand: Wiley-Blackwell
Model: 9781119867388
Format: hardcover
ASIN: 111986738X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 29 December 2022
Listed Since: 01 June 2022

Barcode

No barcode data available

Wiley-Blackwell Statistical Thinking for Non-Statisticians in Drug Regulation

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Biomarker and Early Clinical Development

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Statistical Methods in Biomarker and Early Clinical Development

Success Probability Estimation with Applications to Clinical Trials

Statistical Issues in Drug Development (Statistics in Practice)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)

Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Clinical Trial Biostatistics and Biopharmaceutical Applications

Applied Statistics in the Pharmaceutical Industry: With Case Studies Using S-Plus

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials (Springer Series in Pharmaceutical Statistics)

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)

Statistics in Drug Research: Methodologies and Recent Developments